GRP
PTGX icon

Global Retirement Partners’s Protagonist Therapeutics PTGX Stock Holding History

Global Retirement Partners’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129K Buy
+1,055
New +$110K ﹤0.01% 1878
2025
Q4 		– Sell
-316
Closed -$21K – 4379
2025
Q3 		$21K Hold
316
– – ﹤0.01% 2375
2025
Q2 		$17.5K Buy
+316
New +$15.2K ﹤0.01% 2348
2024
Q4 		$11.7K Sell
304
-44
-13% -$1.92K ﹤0.01% 2337
2024
Q3 		$15.7K Sell
348
-188
-35% -$7.6K ﹤0.01% 2111
2024
Q2 		$18.6K Buy
536
+236
+79% +$6.91K ﹤0.01% 2025
2024
Q1 		$8.68K Hold
300
– – ﹤0.01% 2185
2023
Q4 		$7.39K Hold
300
– – ﹤0.01% 2178
2023
Q3 		$4.79K Hold
300
– – ﹤0.01% 2206
2023
Q2 		$8.29K Hold
300
– – ﹤0.01% 2031
2023
Q1 		$7.33K Sell
300
-700
-70% -$11.8K ﹤0.01% 2034
2022
Q4 		$10.9K Hold
1,000
– – ﹤0.01% 1745
2022
Q3 		$8K Buy
+1,000
New +$9.46K ﹤0.01% 1776

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Global Retirement Partners's PTGX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Protagonist Therapeutics (PTGX) in Q2 2026: 1,055 shares worth $129K. The stake represents ﹤0.01% of the portfolio and ranks #1878 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PTGX as recently as Q3 2025.

Global Retirement Partners first reported a position in PTGX in Q3 2022 and has held it in 13 quarters since. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Global Retirement Partners held 1,055 shares of Protagonist Therapeutics worth $129K as of Q2 2026.
  • Protagonist Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Protagonist Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1878 holding.
  • Global Retirement Partners first reported a position in Protagonist Therapeutics in Q3 2022 and has held it in 13 quarters since.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.